Kinetic studies on phosphorylation of 5-azacytidine with the purified uridine-cytidine kinase from calf thymus.

Summary Uridine-cytidine kinase was purified 330-fold from calf thymus. This enzyme catalyzes the phosphorylation of uridine, cytidine (CR), and the nucleoside analog, 5-azacytidine (5-aza-C) to their respective nucleoside 5′-monophosphates in the presence of Mg ++ and adenosine 5′-triphosphate. The K m values for CR uridine, and 5-aza-C were 40, 50, and 200 µm respectively. Uridine 5′-triphosphate or cytidine 5′-triphosphate inhibited the phosphorylation of these nucleosides; the inhibition was noncompetitive with respect to the nucleoside substrates and competitive with respect to adenosine 5′-triphosphate. CR and uridine were potent competitive inhibitors of 5-aza-C (K i values of 40 and 50 µm, respectively), whereas 5-aza-C was a weak competitive inhibitor of CR (K i value of 200 µm).

[1]  E. Freireich,et al.  Treatment of acute leukemia with 5-azacytidine (NSC-102816). , 1973, Cancer chemotherapy reports.

[2]  M. Tattersall,et al.  Methotrexate or 5-Fluorouracil Mouse 5178 Y Lymphoma Cells following Exposure to Changes in the Deoxyribonucleoside Triphosphate Pools of Updated Version , 2006 .

[3]  P. Stambrook,et al.  Uridine uptake and its intracellular phosphorylation during the cell cycle , 1973, Journal of cellular physiology.

[4]  J. Finklestein,et al.  5-Azacytidine: a new active agent for the treatment of acute leukemia. , 1973, Blood.

[5]  G. Krystal,et al.  The partial purification and properties of uridine kinase from Ehrlich ascites tumor cells. , 1973, Canadian journal of biochemistry.

[6]  H. H. Lloyd,et al.  Kinetics of the reduction in viability of cultured L1210 leukemia cells exposed to 5-azacytidine (NSC-102816). , 1972, Cancer chemotherapy reports.

[7]  A. Čihák,et al.  Dual effect of 5-azacytidine on the synthesis of liver ribonucleic acids. Lack of the relationship between metabolic transformation of orotic acid in vitro and its incorporation in vivo. , 1972, Biochemical pharmacology.

[8]  F. Šorm,et al.  Enhanced stability of uridine kinase from mouse leukemic cells resistant to 5-azacytidine. Thermal inactivation and effect of p-chloromercuribenzoate. , 1971, European journal of biochemistry.

[9]  F. Šorm,et al.  Biochemical mechanisms of drug resistance — XII. Uridine kinases from mouse leukemic cells sensitive and resistant to 5‐azacytidine , 1971, International journal of cancer.

[10]  R. Momparler,et al.  Mammalian deoxynucleoside kinases. II. Deoxyadenosine kinase: purification and properties. , 1971, The Journal of biological chemistry.

[11]  M. Weber,et al.  Phosphate transport, nucleotide pools, and ribonucleic acid synthesis in growing and in density-inhibited 3T3 cells. , 1971, The Journal of biological chemistry.

[12]  L H Li,et al.  Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia. , 1970, Cancer research.

[13]  A. Orengo Regulation of enzymic activity by metabolites. I. Uridine-cytidine kinase of Novikoff ascites rat tumor. , 1969, The Journal of biological chemistry.

[14]  D. Kessel,et al.  Transport of two non-metabolized nucleosides, deoxycytidine and cytosine arabinoside, in a sub-line of the L1210 murine leukemia. , 1968, Biochimica et biophysica acta.

[15]  H. Nakamura,et al.  Metabolism of deoxyribonucleotides. 3. Purification and some properties of nucleoside diphosphokinase of calf thymus. , 1966, The Journal of biological chemistry.

[16]  H. Teraoka,et al.  Metabolism of deoxyribonucleotides. I. Purification and properties of deoxycytidine monophosphokinase of calf thymus. , 1966, The Journal of biological chemistry.

[17]  M. Rossi,et al.  THIN-LAYER CHROMATOGRAPHY OF NUCLEOTIDES, NUCLEOSIDES AND NUCLEIC ACID BASES. , 1965, Biochimica et biophysica acta.

[18]  F. Šorm,et al.  Anabolic transformation of a novel antimetabolite, 5-azacytidine, and evidence for its incorporation into ribonucleic acid , 1965 .

[19]  F. Šorm,et al.  On the metabolism of 5-azacytidine and 5-aza-2'-deoxycytidine in mice , 1965 .

[20]  E. P. Anderson,et al.  FEEDBACK INHIBITION OF URIDINE KINASE BY CYTIDINE TRIPHOSPHATE AND URIDINE TRIPHOSPHATE. , 1964, Biochimica et biophysica acta.

[21]  N. Furlong A rapid assay for nucleotide kinases using C14-or H3-labeled nucleotides. , 1963, Analytical biochemistry.

[22]  O. Sköld Uridine Kinase from Ehrlich Ascites Tumor: Purification and Properties , 1960 .

[23]  Canellakis Es Pyrimidine metabolism. II. Enzymatic pathways of uracil anabolism. , 1957 .

[24]  B. Skrifvars,et al.  Formation of Uridine Phosphates from Uracil in Extracts of Ehrlich Ascites Tumor. , 1957 .